# Immunologic Monitoring and Cellular Products Laboratory

> **NIH NIH P30** · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 2020 · $509,273

## Abstract

Abstract: Immunologic Monitoring and Cellular Products Laboratory (IMCPL)
The goals of the Immunologic Monitoring and Cellular Products Laboratory (IMCPL) are to support the
development of cellular, viral or gene therapies for cancer and monitor immunological responses to these
therapies in patents enrolled in clinical trials at the Hillman Cancer Center (HCC). IMCPL is a unique facility
offering a comprehensive set of state-of-the-art technologies and assays to the HCC investigators conducting
clinical trials with various biotherapies and monitoring immune responses to these therapies. IMCPL also supports
pre-clinical developmental projects for future translation to clinical trials. IMCPL is led by Dr. Theresa Whiteside,
(CII) who oversees a staff of 20 FTE in the facility located within the HCC Research Pavilion. Services are
provided by trained personnel in a CLIA/CAP certified laboratory with independent quality assurance (QA)
oversight. IMCPL primarily supports the clinical and translational CII and CT research programs. In FY2019, the
IMCPL serviced 62 independent clinical trials for 35 HCC members (87% of the usage)/research protocols, all
relevant to the HCC mission of providing novel immunotherapy-driven clinical trials to cancer patients. During the
next project period, IMCPL will add 9 new clean rooms, thus expanding therapeutic cell production capabilities and
plans to increase the repertoire of cellular products for therapy in the future. It is also upgrading its monitoring
capabilities to analyses of single-cell and exosome molecular profiles.

## Key facts

- **NIH application ID:** 10024344
- **Project number:** 2P30CA047904-32
- **Recipient organization:** UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- **Principal Investigator:** Theresa L. Whiteside
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $509,273
- **Award type:** 2
- **Project period:** 1997-09-10 → 2025-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10024344

## Citation

> US National Institutes of Health, RePORTER application 10024344, Immunologic Monitoring and Cellular Products Laboratory (2P30CA047904-32). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10024344. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*